InWith Corporation, which holds key enabling IP in augmented contact lenses, has been at work with Bausch and Lomb (NYSE: BHC) to develop smart contacts for the past year. InWith plans for an Institutional Review Board approval this year on first prototypes. InWith co-founder and CEO Michael Hayes says the unique marriage marriage of highly biocompatible materials with 3-D flexible microelectronics embedded into molded hydrogel devices, which InWith calls “smart biology,” may be on the market “in the near future.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.